| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/20/2000 | WO2000017358A3 Human chaperone proteins |
| 07/20/2000 | WO2000017236A8 Apoptosis related protein and uses therefor |
| 07/20/2000 | WO2000017235A3 Cytokine receptor zalpha11 |
| 07/20/2000 | WO2000016800A3 Methods of treating chronic pain |
| 07/20/2000 | WO2000015795A3 Genes from human chromosome 11p15.5 |
| 07/20/2000 | WO2000015772A3 Recombinant protein production in urine |
| 07/20/2000 | WO2000015660A8 Target of rnaiii activating protein (trap) |
| 07/20/2000 | WO2000015246A3 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 07/20/2000 | WO2000010598B1 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 07/20/2000 | WO2000004156A9 SEROTYPE-SPECIFIC PROBES FOR $i(LISTERIA MONOCYTOGENES) |
| 07/20/2000 | WO2000004149A3 Compositions and methods for therapy and diagnosis of prostate cancer |
| 07/20/2000 | WO2000003012A9 Expression of eukaryotic peptides in plant plastids |
| 07/20/2000 | WO2000002902A9 Novel inhibitors of angiogenesis and tumor growth |
| 07/20/2000 | WO2000002897A9 Delta cleavage products and methods based thereon |
| 07/20/2000 | WO2000000514A9 Synthetic spiroketal pyranes as potent anti-cancer agents |
| 07/20/2000 | WO1999067386A8 Differentially expressed genes in pancreatic cancer and displasia |
| 07/20/2000 | WO1999067373A3 Invertebrate intestinal mucins, cdnas, antibodies and their use |
| 07/20/2000 | WO1999067360A3 Media and methods for expansion of erythroid stem cells for the production of hemoglobin |
| 07/20/2000 | WO1999063094A9 Nucleotide and protein sequences of gpr1 and methods based thereon |
| 07/20/2000 | WO1999063082A9 Isolation of drosophila homolog to mammalian gdnf |
| 07/20/2000 | WO1999054353A3 Human nucleic acid sequences of normal uterus tissue |
| 07/20/2000 | WO1999053931A9 Tumor cells with increased immunogenicity and uses thereof |
| 07/20/2000 | WO1999053046A9 Noncloning technique for expressing a gene of interest |
| 07/20/2000 | WO1999049293A8 Methods, kits and compositions pertaining to detection complexes |
| 07/20/2000 | DE19901009A1 Peptide zur Inhibierung von HBV-Core-Proteinen Peptides to inhibit HBV core proteins |
| 07/20/2000 | DE19901008A1 Peptide zur Inhibierung von HPV E6-Proteinen Peptides for inhibition of HPV-E6 proteins |
| 07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | CA2509345A1 Bacterial cell component-unresponsive model mouse |
| 07/20/2000 | CA2371752A1 Tumor marker zsig62 |
| 07/20/2000 | CA2362484A1 Herbicide target gene and methods |
| 07/20/2000 | CA2361204A1 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | CA2360584A1 Mammalian alpha-helical protein - 12 |
| 07/20/2000 | CA2360577A1 Zlrr3: a human leucine-rich repeat protein |
| 07/20/2000 | CA2360563A1 Novel interferon-.alpha. |
| 07/20/2000 | CA2359843A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling |
| 07/20/2000 | CA2359814A1 Method for the affinity isolation of newly synthesized rna |
| 07/20/2000 | CA2359629A1 Schizochytrium pks genes |
| 07/20/2000 | CA2359504A1 Novel compounds |
| 07/20/2000 | CA2359492A1 Neisseria meningitidis antigen |
| 07/20/2000 | CA2359486A1 Neisseria meningitidis polypeptide basb052 |
| 07/20/2000 | CA2359479A1 Novel complex-forming proteins |
| 07/20/2000 | CA2359365A1 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | CA2359345A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | CA2359335A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 07/20/2000 | CA2359132A1 Bone marrow-specific protein |
| 07/20/2000 | CA2358908A1 Bone stimulating factor |
| 07/20/2000 | CA2358748A1 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | CA2358684A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | CA2356706A1 Novel exendin agonist formulations and methods of administration thereof |
| 07/20/2000 | CA2325359A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | CA2259830A1 Ras activator nucleic acid molecules, proteins and methods of use |
| 07/19/2000 | EP1020529A2 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 07/19/2000 | EP1020528A2 Method for producing secreted proteins |
| 07/19/2000 | EP1020521A1 Fas Ligand inhibitor ( FLINT ) compositions and uses thereof |
| 07/19/2000 | EP1020520A1 Prevention of immune related removal of cells from the mammalian body, mutant PML molecules useful therefor |
| 07/19/2000 | EP1020519A1 Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors |
| 07/19/2000 | EP1020518A1 Transporter genes |
| 07/19/2000 | EP1020517A1 Gene originating in human chondrocyte |
| 07/19/2000 | EP1020516A2 Leptospira vaccine antigens for the prevention of leptospirosis |
| 07/19/2000 | EP1019728A1 Method of activating a novel ligand regulatory pathway |
| 07/19/2000 | EP1019714A2 Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of the presence or absence of a lim-kinase gene |
| 07/19/2000 | EP1019542A1 Methods to modulate blood pressure and diagnose bartter's syndrome type iii |
| 07/19/2000 | EP1019537A1 Bioassay for thyroid stimulating antibodies |
| 07/19/2000 | EP1019532A1 Primers and probes for the amplification, detection and typing of mycoplasma pneumoniae |
| 07/19/2000 | EP1019528A1 Method for assaying proteolytic enzymes using fluorescence-quenched substrates |
| 07/19/2000 | EP1019522A1 Compositions and methods for administering pneumococcal dna |
| 07/19/2000 | EP1019520A1 SCREENING METHODS TO DETECT mRNA TARGETS OF EDITING ENZYMES |
| 07/19/2000 | EP1019515A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment |
| 07/19/2000 | EP1019511A2 STABILIZATION OF ENVELOPE GLYCOPROTEIN TRIMERS BY DISULFIDE BONDS INTRODUCED INTO A gp41 GLYCOPROTEIN ECTODOMAIN |
| 07/19/2000 | EP1019510A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 07/19/2000 | EP1019509A2 Protein involved in abscisic acid signalling |
| 07/19/2000 | EP1019508A1 Tnf-related death ligand |
| 07/19/2000 | EP1019507A1 Amino-terminally truncated rantes as chemokine antagonists |
| 07/19/2000 | EP1019506A1 101 human secreted proteins |
| 07/19/2000 | EP1019505A1 Human hox c10 and polynucleotides encoding |
| 07/19/2000 | EP1019504A1 Isoforms of the human vitamin d receptor |
| 07/19/2000 | EP1019503A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 07/19/2000 | EP1019502A2 Human orphan receptor ntr-1 |
| 07/19/2000 | EP1019500A2 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/19/2000 | EP1019499A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 07/19/2000 | EP1019498A1 Determination of genetic sex in equine species by analysis of y-chromosomal dna sequences |
| 07/19/2000 | EP1019495A1 Transgenic model comprising tcr alpha and beta chains |
| 07/19/2000 | EP1019458A1 Methods of using ice-controlling molecules |
| 07/19/2000 | EP1019440A1 Bis-tetrameric hemoglobin and reagents for its production |
| 07/19/2000 | EP1019439A1 Soluble single-chain t-cell receptor proteins |
| 07/19/2000 | EP1019438A1 Apoptosis-related compounds and their use |
| 07/19/2000 | EP1019437A1 Method for the covalent attachment of polysaccharides to protein molecules |
| 07/19/2000 | EP1019436A1 Acquired resistance npr genes and uses thereof |
| 07/19/2000 | EP1019435A1 Amplification of response from expressed recombinant protein |
| 07/19/2000 | EP1019433A1 Protein composition and process for isolating a protein composition from a muscle source |
| 07/19/2000 | EP1019432A1 The ob receptor and methods of diagnosing and treating weight |
| 07/19/2000 | EP1019092A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 07/19/2000 | EP1019091A1 50 human secreted proteins |
| 07/19/2000 | EP1019085A1 Non-anaphylactic forms of allergens and their use |
| 07/19/2000 | EP1019084A1 Novel antimicrobial polypeptide and methods of use |
| 07/19/2000 | EP1019082A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/19/2000 | EP1019080A2 Modulation of lerk-2-mediated cell adhesion |
| 07/19/2000 | EP1019078A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis |
| 07/19/2000 | EP1019077A1 Novel exendin agonist compounds |